Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
During cerebral malaria there is a state of unarousable coma with malaria infected blood in the peripheral circulation. The condition of coma is due to some other type of infections or hypoglycemia. The presence of retinopathy has been an addition in the clinical diagnosis of both adult and children. The postmortem studies done for observing the pathophysiology of cerebral malaria has found that Plasmodium falciparum infections accounts for majority of the cerebral malaria cases showing a common feature of vascular sequestration in the brain of infected erythrocytes. There is a difference between cerebral malaria in adults and in children. They can be differentiated based on the infected erythrocytes sequestration pattern with variable vascular pathology.
There has been a decline in the cases of malaria death and infections due to the research efforts. But at the same time, there has been an exponential rise in the drug resistance creating a need for new therapeutics. Moreover, the increase in the global temperature will expand the territory of mosquito-borne diseases driving a need to understand the molecular mechanism that underlines this parasitic infection.
The report details the trend, potential and market size of Cerebral Malaria Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Cerebral Malaria Therapeuticsmarket, defines the market attractiveness level of Cerebral Malaria Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Cerebral Malaria Therapeutics industry, describes the types of Cerebral Malaria Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cerebral Malaria Therapeutics market and the development prospects and opportunities of Cerebral Malaria Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cerebral Malaria Therapeutics market in Chapter 13.
By Player:
Ipca Laboratories
Eisai
Novartis
Zydus Cadila
Sanofi
Cipla
By Type:
Quinine
Artemisinin Derivatives
By End-User:
Drug store Hospital pharmacies Retail pharmacies Online pharmacies
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Cerebral Malaria Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Cerebral Malaria Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Cerebral Malaria Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Cerebral Malaria Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Cerebral Malaria Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Cerebral Malaria Therapeutics Consumption (2017-2022)
-
7.2 United States Cerebral Malaria Therapeutics Consumption (2017-2022)
-
7.3 Europe Cerebral Malaria Therapeutics Consumption (2017-2022)
-
7.4 China Cerebral Malaria Therapeutics Consumption (2017-2022)
-
7.5 Japan Cerebral Malaria Therapeutics Consumption (2017-2022)
-
7.6 India Cerebral Malaria Therapeutics Consumption (2017-2022)
-
7.7 South Korea Cerebral Malaria Therapeutics Consumption (2017-2022)
8 Region and Country-wise Cerebral Malaria Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Cerebral Malaria Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Cerebral Malaria Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Cerebral Malaria Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Cerebral Malaria Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Cerebral Malaria Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Cerebral Malaria Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Cerebral Malaria Therapeutics Consumption Forecast (2022-2028)
9 Global Cerebral Malaria Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Cerebral Malaria Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Quinine Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Artemisinin Derivatives Consumption and Growth Rate (2017-2022)
-
9.2 Global Cerebral Malaria Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Drug store Hospital pharmacies Retail pharmacies Online pharmacies Consumption and Growth Rate (2017-2022)
10 Global Cerebral Malaria Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Cerebral Malaria Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Quinine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Artemisinin Derivatives Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Cerebral Malaria Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Drug store Hospital pharmacies Retail pharmacies Online pharmacies Consumption Forecast and Growth Rate (2022-2028)
11 Global Cerebral Malaria Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Cerebral Malaria Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Cerebral Malaria Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Cerebral Malaria Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Cerebral Malaria Therapeutics Market Competitive Analysis
-
14.1 Ipca Laboratories
-
14.1.1 Ipca Laboratories Company Details
-
14.1.2 Ipca Laboratories Cerebral Malaria Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Ipca Laboratories Cerebral Malaria Therapeutics Product and Service
-
14.2 Eisai
-
14.2.1 Eisai Company Details
-
14.2.2 Eisai Cerebral Malaria Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Eisai Cerebral Malaria Therapeutics Product and Service
-
14.3 Novartis
-
14.3.1 Novartis Company Details
-
14.3.2 Novartis Cerebral Malaria Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novartis Cerebral Malaria Therapeutics Product and Service
-
14.4 Zydus Cadila
-
14.4.1 Zydus Cadila Company Details
-
14.4.2 Zydus Cadila Cerebral Malaria Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Zydus Cadila Cerebral Malaria Therapeutics Product and Service
-
14.5 Sanofi
-
14.5.1 Sanofi Company Details
-
14.5.2 Sanofi Cerebral Malaria Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Sanofi Cerebral Malaria Therapeutics Product and Service
-
14.6 Cipla
-
14.6.1 Cipla Company Details
-
14.6.2 Cipla Cerebral Malaria Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Cipla Cerebral Malaria Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Cerebral Malaria Therapeutics
-
Figure Cerebral Malaria Therapeutics Picture
-
Table Global Cerebral Malaria Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cerebral Malaria Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cerebral Malaria Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Cerebral Malaria Therapeutics Consumption by Country (2017-2022)
-
Figure United States Cerebral Malaria Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Cerebral Malaria Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Cerebral Malaria Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Cerebral Malaria Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Cerebral Malaria Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Cerebral Malaria Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Cerebral Malaria Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Cerebral Malaria Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Cerebral Malaria Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Cerebral Malaria Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Cerebral Malaria Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Cerebral Malaria Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Cerebral Malaria Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Quinine Consumption and Growth Rate (2017-2022)
-
Figure Global Artemisinin Derivatives Consumption and Growth Rate (2017-2022)
-
Figure Global Drug store Hospital pharmacies Retail pharmacies Online pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Quinine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Artemisinin Derivatives Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drug store Hospital pharmacies Retail pharmacies Online pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Cerebral Malaria Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Cerebral Malaria Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Ipca Laboratories (Foundation Year, Company Profile and etc.)
-
Table Ipca Laboratories Cerebral Malaria Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ipca Laboratories Cerebral Malaria Therapeutics Product and Service
-
Table Eisai (Foundation Year, Company Profile and etc.)
-
Table Eisai Cerebral Malaria Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Cerebral Malaria Therapeutics Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Cerebral Malaria Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Cerebral Malaria Therapeutics Product and Service
-
Table Zydus Cadila (Foundation Year, Company Profile and etc.)
-
Table Zydus Cadila Cerebral Malaria Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zydus Cadila Cerebral Malaria Therapeutics Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Cerebral Malaria Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Cerebral Malaria Therapeutics Product and Service
-
Table Cipla (Foundation Year, Company Profile and etc.)
-
Table Cipla Cerebral Malaria Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cipla Cerebral Malaria Therapeutics Product and Service
-
